CONTINUING TRAINING (Q4205449): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en, and other parts: Adding English translations) |
||||||||||||||
| label / en | label / en | ||||||||||||||
CONTINUING TRAINING | |||||||||||||||
| Property / summary | |||||||||||||||
CONTINUING TRAINING (English) | |||||||||||||||
| Property / summary: CONTINUING TRAINING (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: CONTINUING TRAINING (English) / qualifier | |||||||||||||||
point in time: 1 February 2022
| |||||||||||||||
Revision as of 06:47, 1 February 2022
Project Q4205449 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CONTINUING TRAINING |
Project Q4205449 in Italy |
Statements
900.0 Euro
0 references
1,800.0 Euro
0 references
50.0 percent
0 references
LEO PHARMA MANUFACTURING ITALY S.R.L.
0 references
FORMAZIONE CONTINUA VI (Italian)
0 references
SEGRATE
0 references